AbbVie Expands Neuroscience Portfolio with $8.7 Billion Acquisition of Cerevel Therapeutics
AbbVie has announced plans to acquire Cerevel Therapeutics, a neuroscience drugmaker, for $8.7 billion, marking its [...]
Consolidation of US Hospitals Leads to Increased Profits but Not Improved Care Quality, Study Finds
The consolidation of US hospitals increased between 2000 and 2020, with multi-unit hospital systems now owning [...]
AbbVie Expands Oncology Footprint with $10.1 Billion Acquisition of ImmunoGen
AbbVie, a pharmaceutical giant, announced its plan to acquire ImmunoGen, a clinical-stage biotech company specializing in [...]
Montrose Regional Health Joins Guardian Research Network’s Nationwide Healthcare Research Consortium
Guardian Research Network (GRN) has announced that Montrose Regional Health (MRH), a critical healthcare facility in [...]
EMD Serono to Relocate Headquarters to Boston’s Seaport District, Embracing Hybrid Work and Collaboration
EMD Serono, the US pharma subsidiary of Merck KGaA, is set to move its headquarters to [...]
Carl Icahn Files Lawsuit Against Illumina Board Over Controversial Grail Acquisition, Seeks Repayment and Board Removal
Billionaire Carl Icahn has launched a class-action lawsuit against the board of Illumina, claiming that they [...]
Teva and Cephalon Lose Appeal Against $60 Million Fine in Pay-for-Delay Scheme
Teva and its subsidiary Cephalon have lost their appeal against more than $60 million in fines [...]
Optimizing Clinical Trials for Greater Payer Acceptance and Enhanced Patient Access
Biopharma manufacturers face challenges in conveying the clinical value of their medicines to payers due to [...]
Recent Biopharmaceutical Updates: Workplace Cuts at Sana, NASH Treatment Setbacks, ALS Treatment Appeals, and Alnylam’s Future
Recent updates from the biopharmaceutical world: Sana Biotechnology: The company is laying off approximately one-third of [...]
FDA Denies Alnylam Pharmaceuticals’ Expansion Plans for Onpattro Treatment
The FDA has denied Alnylam Pharmaceuticals' request to expand the use of its siRNA injection Onpattro for the treatment of [...]
AbbVie Acquires Mitokinin for $110M Upfront to Enhance its Neuroscience Pipeline
Pharmaceutical company AbbVie has purchased biotech Mitokinin for $110 million upfront, potentially adding $545 million in milestone payments. The deal [...]
2023 Nobel Prize in Medicine Awarded to mRNA Researchers Katalin Karikó and Drew Weissman
Katalin Karikó and Drew Weissman, two pioneers of mRNA research, were awarded the 2023 Nobel Prize in Medicine or Physiology [...]
Integration of Digital Targeting in Addressable TV: Implications for Healthcare Marketers
Addressable TV—which uses digital targeting and measurements for television advertisements—is changing the marketing landscape. It allows healthcare marketers to reach [...]
Philip Morris Introduces LEVIA: A Tobacco-Free Alternative for IQOS Device
Philip Morris International (PMI) has announced a new product for its IQOS 'heat-not-burn' device: a tobacco-free stick named LEVIA. The [...]
Roche Acquires Two RNA-Targeted Drug Programs for Alzheimer’s and Huntington’s from Ionis Pharmaceuticals
Roche has obtained two RNA-targeted drug programs for Alzheimer's and Huntington's diseases from Ionis Pharmaceuticals. The deal involves a $60 [...]
Christine Davis Appointed as New President of Ontada
Ontada, a McKesson business focusing on oncology real-world data and evidence, has appointed Christine Davis as [...]
The Illusions of the U.S. Pharmaceutical Industry: Misdirection in Drug Pricing, Innovation, and Regulation
The U.S. biopharmaceutical industry uses subtle illusion techniques similar to magicians to distract Americans from truths [...]
Seagen and Nurix Partner to Develop New Cancer Therapy, Deal Could Reach $3.4 Billion
Seattle-based biotech Seagen will partner with Nurix to develop degrader-antibody conjugates (DACs), a new type of cancer therapy. Seagen is [...]
Novo Nordisk’s Obesity Drugs Reshape Denmark’s Economy, Sparking Economic and Policy Debates
Novo Nordisk, a Danish firm initially known for producing diabetes drugs, has become highly influential on Denmark's economy due to [...]
Medicare to Negotiate Prices for 10 High-Cost Drugs Under New Democratic Reform Law
Medicare will negotiate prices for ten high-cost drugs, including major diabetes medications and blood thinners, as part of a drug [...]
Cellares Secures $255M in Series C Round of Funding
Cellares, a cell therapy manufacturer based in South San Francisco, announced a $255 million series C investment round to finish [...]
Leo Pharma Acquires Timber Pharmaceuticals for $36M to Bolster Dermatology Pipeline
Leo Pharma has agreed to acquire US-based Timber Pharmaceuticals, a clinical-stage biopharma company that develops treatments for rare skin conditions, [...]
Boehringer Ingelheim Files Lawsuit Against U.S. Government Over Medicare’s Drug Price Negotiation Power
Boehringer Ingelheim has filed a lawsuit against the U.S. government, arguing that Medicare's new power to negotiate drug prices is [...]
Bruker to Acquire PhenomeX for $108M
Bruker Corporation is actively acquiring PhenomeX in a cash deal valued at $108 million. PhenomeX, a product of Berkeley Lights' [...]
Preliminary Data Suggests Moderna’s Updated Covid-19 Vaccine Effective Against Expected Fall Variants
Moderna's preliminary data suggests that its updated COVID-19 vaccine can effectively combat expected variants this fall, including Eris and Fornax. [...]
